 |
|
|
|
EXPRESS® 3/Lp Reference Page
Description
Bovine Rhinotracheitis - Virus Diarrhea Vaccine Modified Live Virus and Leptospira Pomona Bacterin. Express® 3/Lp contains neomycin as a preservative.
Features
Contains IBR-BVD Types 1 & 2 modified live virus and L pomona.
IBR fraction stimulates serological and cell mediated immune (CMI) response.
2 mL dose.
Benefits
Provides a proven efficacious immune response in healthy, susceptible cattle.
Provides extremely high serological titers and broad, effective coverage for BVD.
Includes BVD Type 2 protection.
Provides cattle with the capability to launch a serological and CMI response against an IBR challenge.
No milk withholding.
Advantages
Express 3/Lp administration allows cattle to launch a serological and CMI response against an IBR challenge and provides broad BVD protection with extremely high serological titers.
Dosage & Administration
Rehydrate one bottle of modified live virus vaccine by aseptically adding one bottle of liquid bacterin diluent. Using aseptic technique inject a 2 mL dose IM. Repeat in 14 to 28 days and once annually. Calves vaccinated before 6 months of age should be revaccinated at 6 months. A 2 mL booster dose is recommended prior to time of stress or exposure.
Precautions
Store out of direct sunlight at 35∞ - 45∞ F (2∞ - 7∞ C). Avoid freezing. Shake well before using. Use entire contents when first opened. Do not vaccinate within 21 days of slaughter. Do not use in pregnant cows or in calves nursing pregnant cows. Burn containers and all unused contents. Injection site swelling may occur. Anaphylactoid reactions may occur.
Antidote: Epinephrine.
Uses
Express 3/Lp is recommended for vaccination of healthy, susceptible cattle as an aid in the reduction of disease caused by IBR, BVD Types 1 & 2, L pomona.
Warning
Animal inoculation only. Accidental injection to humans can cause serious local reactions. Contact a physician immediately if accidental injection occurs.
It is possible that healthy appearing cattle can be persistently infected with or incubating virulent BVD virus at the time of vaccination. BVD vaccine is contraindicated in persistently infected cattle and use should be limited only to healthy, immunocompetent, unstressed, non-pregnant cattle.
Product Information
|
Name
|
Code
|
Size
|
|
Expressô 3/Lp
|
109-511
|
20 mL 5x10 doses
|
|
Expressô 3/Lp
|
109-531
|
100 mL 5x50 doses
|
|
-
|
-
|
-
|
|
-
|
-
|
-
|
|
-
|
-
|
-
|
Highlights
- Protects against IBR-BVD Types 1 & 2-L pomona.
- Provides broad coverage and extremely high serological titer to BVD.
- IBR fraction stimulates a serological and CMI response.
- Use in cattle of all ages.
- 2 mL dose.
Contact Information
Boehringer Ingelheim Vetmedica, Inc.
2621 North Belt Highway
St. Joseph, MO 64506
Information: 800-821-7467
Sales: 800-325-9167
Fax: 816-236-2717
email: wayne.cole@boehringer-ingelheim.com
internet: http://www.bi-vetmedica.com
General Product Information Documents
Technical Bulletins
Audio & Video
Marketing Documents
Product Photos and Product Art
|
|
|
|
|
